A modified DNA vaccine to p53 induces protective immunity to challenge with a chemically induced sarcoma cell line (Q40715246)

23 September 2017

A modified DNA vaccine to p53 induces protective immunity to challenge with a chemically induced sarcoma cell line (English)

1 reference

23 September 2017

Honying Deng

1

1 reference

23 September 2017

Dariusz Kowalczyk

2

1 reference

23 September 2017

InSug O

3

1 reference

23 September 2017

Magdalena Blaszczyk-Thurin

4

1 reference

23 September 2017

Zhi Quan Xiang

5

1 reference

23 September 2017

Wynetta Giles-Davis

6

1 reference

23 September 2017

Hildegund C J Ertl

7

1 reference

23 September 2017

1 January 2002

1 reference

23 September 2017

12

1 reference

based on heuristic

inferred from page(s)

published in

Cellular Immunology

1 reference

23 September 2017

215

1 reference

23 September 2017

20-31

1 reference

23 September 2017

1

1 reference

Mutations in the p53 gene occur in diverse human tumour types

23 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900004-7

MCG10, a novel p53 target gene that encodes a KH domain RNA-binding protein, is capable of inducing apoptosis and cell cycle arrest in G(2)-M

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900004-7

Inhibition of c-Jun N-terminal kinase 2 expression suppresses growth and induces apoptosis of human tumor cells in a p53-dependent manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900004-7

The spectrum of mutations at the p53 locus. Evidence for tissue-specific mutagenesis, selection of mutant alleles, and a "gain of function" phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900004-7

Change in oligomerization specificity of the p53 tetramerization domain by hydrophobic amino acid substitutions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900004-7

Influence of interleukin 12 on p53 peptide vaccination against established Meth A sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900004-7

A mouse mutant p53 product recognized by CD4+ and CD8+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900004-7

Primary proliferative T cell response to wild-type p53 protein in patients with breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900004-7

Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte clone recognizing a wild-type p53-derived peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900004-7

The dihedral symmetry of the p53 tetramerization domain mandates a conformational switch upon DNA binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900004-7

Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900004-7

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900004-7

Rabies virus nucleoprotein expressed in and purified from insect cells is efficacious as a vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900004-7

A monoclonal antibody to a multiphosphorylated, conformational epitope at the carboxy-terminus of p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900004-7

Co-delivery of T helper 1-biasing cytokine genes enhances the efficacy of gene gun immunization of mice: studies with the model tumor antigen beta-galactosidase and the BALB/c Meth A p53 tumor-specific antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900004-7

Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900004-7

p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900004-7

Immune responses to nucleic acid vaccines to rabies virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900004-7

Induction of MHC class I-restricted CTL response by DNA immunization with ubiquitin-influenza virus nucleoprotein fusion antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900004-7

p53 as a target for cancer vaccines: recombinant canarypox virus vectors expressing p53 protect mice against lethal tumor cell challenge.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900004-7

CD40 activation enhances the magnitude of cellular immune responses against p53 but not the avidity of the effectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900004-7

Dendritic cells transduced with wild-type p53 gene elicit potent anti-tumour immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900004-7

The mode of presentation and route of administration are critical for the induction of immune responses to p53 and antitumor immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900004-7

Genetically modified bone marrow-derived dendritic cells expressing tumor-associated viral or "self" antigens induce antitumor immunity in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900004-7

DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900004-7

A comparison of the biological activities of wild-type and mutant p53.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900004-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0008-8749(02)00004-7

1 reference

23 September 2017

1 reference